By Naveen Athrappully The U.S. Food and Drug Administration (FDA) ordered two respiratory syncytial virus (RSV) vaccine manufacturers to include a potentially paralytic side effect warning related to nerve damage on product labels. The manufacturers, GSK and Pfizer, manufacturing Arexvy and Abrysvo vaccines respectively, must now include a warning stating a risk of Guillain-Barre syndrome […]
Tag: Guillain-Barré Syndrome
A condition in which the immune system attacks the nerves.
The condition may be triggered by an acute bacterial or viral infection.
Symptoms start as weakness and tingling in the feet and legs that spread to the upper body. Paralysis can occur.
Special blood treatments (plasma exchange and immunoglobulin therapy) can relieve symptoms. Physical therapy is needed.
